Omixon Biocomputing Kft.

https://www.omixon.com

Omixon specialises in the analysis of targeted Next Generation Sequencing (NGS) data. Using our Target application suite we offer high resolution HLA typing. We also help scientists and clinicians to investigate challenging genomic regions such as breast cancer susceptibility genes (BRCA1 and BRCA2), cystic fibrosis gene (CFTR), as well as custom panels. *

	Start	2004-11-01 established
	Industry	sequencing software
	Person	Bérces, Attila (Omixon 200411– CEO + Founder)
	Person 2	Hague, Tim (Omixon 201311 CEO)

	Region	Budapest
	Country	Hungary
	Street	2 Hauszmann u.
	City	1117 Budapest
	Tel	+36-70-574-8001
		Address record changed: 2024-01-05

Basic data	Employees	n. a.

		* Document for »About Section«:

		Record changed: 2018-10-31

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]